^Rogers TB, Inesi G, Wade R, Lederer WJ (1995). “Use of thapsigargin to study Ca2+ homeostasis in cardiac cells”. Biosci. Rep.15 (5): 341–9. doi:10.1007/BF01788366. PMID8825036.
^Rasmussen U, Brøogger Christensen S, Sandberg F (1978). “Thapsigargine and thapsigargicine, two new histamine liberators from Thapsia garganica L.”. Acta Pharm. Suec.15 (2): 133-140. PMID79299.
^Hakii, H.; Fujiki, H.; Suganuma, M.; Nakayasu, M.; Tahira, T.; Sugimura, T.; Scheuer, P. J.; Christensen, S. B. (1986). “Thapsigargin, a histamine secretagogue, is a non-12-O-tetradecanolphorbol-13-acetate (TPA) type tumor promoter in two-stage mouse skin carcinogenesis”. J. Cancer Res. Clin. Oncol.111 (3): 177–181. doi:10.1007/BF00389230.
^Eckstein-Ludwig U, Webb RJ, Van Goethem ID, East JM, Lee AG, Kimura M, O'Neill PM, Bray PG, Ward SA, Krishna S (August 2003). “Artemisinins target the SERCA of Plasmodium falciparum”. Nature424 (6951): 957–61. doi:10.1038/nature01813. PMID12931192.
^Golenser J, Waknine JH, Krugliak M, Hunt NH, Grau GE (2006). “Current perspectives on the mechanism of action of artemisinins”. Int. J. Parasitol.36 (14): 1427–41. doi:10.1016/j.ijpara.2006.07.011. PMID17005183.